Mitigating Compliance & Security Risks for Biotechs
Life science companies manage a lot of data. It is mission-critical to understand their compliance needs (GxP, Part 11), their partner ecosystem (CROs, labs), and data governance concerns (GDPR, CCPA) not only through an infrastructure perspective, but also their security and compliance requirements. This is driving MSPs to reexamine their high-value offerings and expand their product line for this segment with explosive growth.
Join us to hear Alok Tayi, Ph.D., VP of Life Sciences address these challenges and how Egnyte for Life Sciences provides a repository for collaboration, compliance and control over FDA-regulated data, including:
· A look at the life science industry and its compliance risks
· Why secure remote collaboration is emerging as a bottleneck for emerging biotechs
· How compliance is managed + implemented within LS companies